Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Xometry Continues Rapid Expansion of Global Supplier Base, With More Than 4,200 Active Suppliers On Its AI-Driven Marketplace
November 20, 2024
From
Xometry, Inc.
Via
GlobeNewswire
Tickers
XMTR
Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
November 20, 2024
From
Celldex Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CLDX
Playtika Holding Corp. Completes Strategic Acquisition of SuperPlay, Enhancing Portfolio with Hit Mobile Games Dice Dreams and Domino Dreams
November 20, 2024
From
Playtika Holding Corp.
Via
GlobeNewswire
Tickers
PLTK
Work More Comfortably Under and Around Cars with New MaxJax Reclining Creeper Seat
November 20, 2024
From
MaxJax
Via
GlobeNewswire
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Tickers
ARDX
Millennials Primed to Lead 2024 Holiday Shopping Season as Nearly Two in Three Expect Their Income Will Increase in Next Year
November 20, 2024
From
TransUnion
Via
GlobeNewswire
Tickers
TRU
CDP Partners With Watershed To Drive Its Own Environmental Disclosure
November 20, 2024
From
Watershed
Via
GlobeNewswire
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting
November 20, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
Tickers
CGON
Graphiant Predicts Transformative Changes in Enterprise Connectivity and Data Assurance for 2025
November 20, 2024
From
Graphiant
Via
GlobeNewswire
Enlivex Adopts Bitcoin Treasury Reserve Strategy
November 20, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Tickers
ENLV
StarTree Unveils New Features to Tackle Data Management and Security Challenges for Scaling Real-Time Analytics
November 20, 2024
From
StarTree, Inc.
Via
GlobeNewswire
Stingray Expands Entertainment Offerings; Launches Seven New Streaming Channels on Xfinity Platforms
November 20, 2024
From
Stingray Group Inc.
Via
GlobeNewswire
Tickers
TSX:RAY-A
TSX:RAY-B
BriteCore Unveils 2024 Core Systems Report
November 20, 2024
From
BriteCore
Via
GlobeNewswire
Jack Pattillo, Former Rooster Teeth Content Creator, Twitch Streamer, and YouTuber, Named Community Manager of Channel37
November 20, 2024
From
Channel37
Via
GlobeNewswire
Salsify Appoints David Forlizzi as New Chief Financial Officer
November 20, 2024
From
Salsify
Via
GlobeNewswire
EY Announces Eric Reimer of Healthmap Solutions as an Entrepreneur Of The Year® 2024 National Award Winner
November 20, 2024
From
Healthmap Solutions
Via
GlobeNewswire
Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
November 20, 2024
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
Locad raises $9m for smart digital logistics engine to expand globally
November 20, 2024
From
Locad
Via
GlobeNewswire
Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio
November 20, 2024
From
Route 92 Medical, Inc.
Via
GlobeNewswire
Rezolve Ai and Google Sign Strategic Partnership to Revolutionize Retail and Consumer Commerce with Exclusive AI-Powered Solutions
November 20, 2024
From
Rezolve AI Ltd
Via
GlobeNewswire
Tickers
RZLV
D. Boral Capital acted as Sole Bookrunner for Nature's Miracle Holding Inc. (NASDAQ: NMHI) in Connection with its $3.0 Million Public Offering
November 20, 2024
From
D. Boral Capital
Via
GlobeNewswire
Tickers
NMHI
Nature’s Fynd and Justine Lupe from “Nobody Wants This” Invite Fans to Brunch In Los Angeles
November 20, 2024
From
Nature's Fynd
Via
GlobeNewswire
Lunawood strengthens its position in the United States – a joint venture begins thermal modification of local wood species
November 20, 2024
From
Oy Lunawood Ltd
Via
GlobeNewswire
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
November 20, 2024
From
ZyVersa Therapeutics
Via
GlobeNewswire
Tickers
ZVSA
ACOs Using Arcadia and CareJourney Achieve 1.5x More Savings Than National Average
November 20, 2024
From
Arcadia
Via
GlobeNewswire
Clearlight® Unveils Exclusive VRT Spotify Playlists Created to Amplify Every Infrared Sauna Session
November 20, 2024
From
Clearlight® — Infrared Saunas and Wellness Solutions
Via
GlobeNewswire
HydroGraph Receives Purchase Order for Four Novel Graphenes from Global Automotive Customer
November 20, 2024
From
Hydrograph Clean Power Inc.
Via
GlobeNewswire
Tickers
CSE:HG
HGRAF
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
November 20, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
November 20, 2024
From
Ocugen
Via
GlobeNewswire
Tickers
OCGN
Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
November 20, 2024
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Tickers
APTO
TSX:APS
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.